Actinium Pharmaceuticals Inc (ATNM)

[apollo1452]

August could be a big month for ATNM. They have a DMC meeting for Iomab-B followed by an update. Also, awaiting updates on Actimab-A and Actimab-M which are due any day now.

Not worried about the trial completion dates being moved back. Iomab-B & Actimab-A have good chances of being halted early anyway. As long as we get regular updates all should be good. ATNM is setting themselves up for success, they've done a good job of enrolling patients who are most likely to benefit from the treatment.

Recall also, & this is very important, that the supply issues of actinium-225 have been addressed. The June 21 Dept of Energy article discussed supply issues that meant less science got done. Now the DOE has developed a new process that will supply 20 times more actinium-225 than previously. Obviously, a huge development for ATNM. The same article mentioned "In clinical trials treating Late Stage prostate cancer patients, actinium-225 wiped out the cancer with 3 treatments..." Very Impressive...